China Infrastructure Construction Corp. (CHNC) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
DELISTED
What happened to China Infrastructure Construction Corp. (CHNC) stock?
China Infrastructure Construction Corp. (CHNC) no longer trades on public markets. The figures below are historical and are not a current quote.
P/E 0.03 means the share price is 0.03 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $5.04M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
China Infrastructure Construction Corp. (CHNC). China Infrastructure Construction Corp. focuses on medical cannabis education and related services. The company operates a fertility and sleep center in Houston, Texas, and offers online education globally. Market cap: $5.04M, Sector: Healthcare.
Last analyzed: Mar 17, 2026Analyst Coverage for CHNC: CHNC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHNC against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
CHNC: 1/2 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
China Infrastructure Construction Corp. (CHNC) Healthcare & Pipeline Overview
China Infrastructure Construction Corp. provides medical cannabis education and related services, including clinical trials and sleep disorder treatments. Operating in the United States, Latin America, and globally through online platforms, the company distinguishes itself through its Pharmacology University and fertility/sleep center, amidst a competitive healthcare landscape.
What Is the Investment Thesis for CHNC?
China Infrastructure Construction Corp. presents a speculative investment opportunity within the medical cannabis education sector. The company's focus on online education and specialized services like clinical trials and sleep disorder treatments offers potential for growth, particularly as the medical cannabis market expands. With a market capitalization of $5.04M and a negative P/E ratio of -15.64, the company's financial performance requires careful monitoring. Key value drivers include the expansion of Pharmacology University's online education programs and the success of its fertility and sleep center. However, investors should be aware of the risks associated with OTC-traded stocks and the competitive landscape of the healthcare and cannabis industries. The company's beta of -0.22 suggests a low correlation with the overall market.
Based on FMP financials and quantitative analysis
CHNC Key Highlights
Market capitalization of $5.04M indicates a micro-cap company with high growth potential but also significant risk.
- Gross margin of 66.6% suggests strong pricing power in its niche market of medical cannabis education and services.
- Negative P/E ratio of -15.64 reflects current unprofitability, requiring scrutiny of future earnings potential.
- Profit margin of -291.8% indicates substantial losses, highlighting the need for improved cost management and revenue generation.
- Beta of -0.22 suggests the stock is less volatile than the market, potentially offering some downside protection.
Who Are CHNC's Competitors?
CHNC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BCBCF The BC Bud Corporation | $0.04 | -3.31% | $5.98M | — |
| CLSH CLS Holdings USA, Inc. | $0.04 | 0.00% | $5.94M | — |
| FFLWF Fire & Flower Holdings Corp. | $0.12 | -44.37% | $5.42M | — |
| AVCNF Avicanna Inc. | $0.08 | 0.00% | $10.6M | 529-signal |
| PLNH Planet 13 Holdings Inc. | $0.13 | -7.14% | $42.7M | 429-signal |
| DBCCF Decibel Cannabis Company Inc. | $1.27 | -3.39% | $49.0M | 459-signal |
| ZYBT Zhengye Biotechnology Holding Limited | $1.59 | +1.27% | $75.4M | 465-pillar |
| CWBHF Charlotte's Web Holdings, Inc. | $0.33 | -3.93% | $88.4M | 519-signal |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are CHNC's Key Strengths?
Specialized expertise in medical cannabis education.
- Integrated service offerings including education, consulting, and clinical services.
- Online education platform with global reach.
- Established fertility and sleep center in Houston.
What Are CHNC's Weaknesses?
Small market capitalization and limited financial resources.
- Negative profitability and high operating losses.
- Dependence on the evolving regulatory landscape of the medical cannabis industry.
- Limited brand recognition and market share.
What Could Drive CHNC Stock Higher?
Expansion of online education programs through Pharmacology University.
- Increasing acceptance and legalization of medical cannabis in new markets.
- Potential partnerships with healthcare providers and cannabis dispensaries.
- Development of new clinical trial services focused on medical cannabis.
- Enhancement of fertility and sleep center services in Houston.
What Are the Key Risks for CHNC?
Regulatory changes and legal restrictions on medical cannabis.
- Increasing competition from other educational platforms and healthcare providers.
- Small market capitalization and limited financial resources.
- Negative profitability and high operating losses.
- Economic downturns and reduced consumer spending.
What Are the Growth Opportunities for CHNC?
- Expansion of Online Education Programs: China Infrastructure Construction Corp. can capitalize on the growing demand for medical cannabis education by expanding its online programs through Pharmacology University.
- Geographic Expansion into Latin America: The Latin American medical cannabis market is rapidly expanding, with countries like Colombia and Mexico legalizing medical cannabis. China Infrastructure Construction Corp. can leverage its existing presence in Latin America to establish new educational centers and partnerships, tapping into a high-growth market with increasing demand for medical cannabis education and services. This expansion can be achieved through strategic alliances and franchising opportunities.
- Development of Specialized Clinical Trial Services: CHNC can enhance its service offerings by developing specialized clinical trial services focused on medical cannabis applications. The global clinical trials market is projected to reach $68.9 billion by 2028, presenting a significant opportunity for CHNC to generate revenue through clinical research and development. This can involve partnerships with pharmaceutical companies and research institutions.
- Enhancement of Fertility and Sleep Center Services: The company can enhance its fertility and sleep center in Houston by offering advanced diagnostic and treatment options. The global sleep disorder market is projected to reach $112.7 billion by 2027, while the fertility services market is expected to reach $36 billion by 2026. CHNC can attract more patients by investing in state-of-the-art technology and expanding its range of services.
- Strategic Partnerships and Acquisitions: China Infrastructure Construction Corp. can pursue strategic partnerships and acquisitions to expand its market reach and service offerings. Collaborating with other companies in the healthcare and cannabis industries can provide access to new markets, technologies, and expertise. This can involve partnerships with cannabis dispensaries, healthcare providers, and educational institutions.
What Are CHNC's Competitive Advantages?
- Specialized Focus: Niche focus on medical cannabis education and related services.
- Proprietary Content: Unique educational content developed through Pharmacology University.
- Integrated Services: Combination of education, consulting, and clinical services.
- First-Mover Advantage: Early entrant in the medical cannabis education market.
What Does CHNC Do?
Founded in 2003 and headquartered in Houston, Texas, China Infrastructure Construction Corp. (CHNC) operates within the healthcare sector, focusing on the burgeoning medical cannabis industry. The company's core business revolves around providing educational systems centered on medical cannabis, extending its reach across the United States, Latin America, and worldwide via online education platforms. CHNC distinguishes itself by offering specialized services in therapeutic areas such as clinical trials and sleep disorders, including infertility treatments, through its fertility and sleep center located in Houston. CHNC's educational arm, Pharmacology University, delivers education, consulting, digital publishing, marketing, and franchising services related to medical cannabis. This multifaceted approach positions the company as a knowledge hub within the evolving cannabis market. While the company's market capitalization is modest, its comprehensive service offerings and educational focus provide a unique niche in the healthcare and cannabis sectors. The company's gross margin stands at 66.6%, indicating a strong potential for profitability despite a current negative profit margin of -291.8%.
What Products and Services Does CHNC Offer?
- Provides educational systems focused on medical cannabis.
- Offers online education programs through Pharmacology University.
- Provides services in clinical trials related to medical cannabis.
- Operates a fertility and sleep center in Houston, Texas.
- Offers treatments for sleep disorders, including resulting infertility.
- Provides education, consulting, digital publishing, and marketing services related to medical cannabis.
- Offers franchising opportunities related to medical cannabis education.
How Does CHNC Make Money?
- Generates revenue through online education programs and courses.
- Provides consulting and marketing services to businesses in the medical cannabis industry.
- Operates a fertility and sleep center, generating revenue through patient services.
- Offers franchising opportunities for Pharmacology University.
What Industry Does CHNC Operate In?
China Infrastructure Construction Corp. operates in the evolving medical cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of medical cannabis for various therapeutic applications, driving demand for education and related services. CHNC competes with other educational platforms and healthcare providers in the sleep disorder and fertility treatment sectors. Companies like ACRDF (Acreage Holdings) and BCBCF (BevCanna Enterprises Inc.) represent competitors in the broader cannabis market, while CLSH (Clearside Biomedical Inc.) operates in the pharmaceutical space. The industry's growth is fueled by ongoing research, changing regulations, and increasing consumer awareness.
Who Are CHNC's Key Customers?
- Individuals seeking education on medical cannabis.
- Healthcare professionals interested in learning about medical cannabis applications.
- Businesses in the medical cannabis industry seeking consulting and marketing services.
- Patients seeking treatment for sleep disorders and infertility.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price 5 days old
- ● No filing on record
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 4 snapshots
| 2026-08-23 | 55 |
| 2026-08-24 | 55 |
| 2026-08-25 | 55 |
| 2026-08-26 | 55 |
What changed?
The score has stayed at 55.
Over the same 3 days the stock moved +0.0%.
Company Profile
China Infrastructure Construction Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Houston, US. The company is led by CEO Dante Picazo. CHNC has traded publicly since 2009.
Financial Health
China Infrastructure Construction Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
Key Financial Metrics
Return on equity for China Infrastructure Construction Corp. stands at 122.6%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -1.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -4.9%, the inverse of the P/E and a quick read on earnings relative to price.
CHNC Valuation & Market Position
With a $5.04M market cap, China Infrastructure Construction Corp. sits in the micro-cap segment of the market.
CHNC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Specialized expertise in medical cannabis education.
- Integrated service offerings including education, consulting, and clinical services.
- Online education platform with global reach.
- Established fertility and sleep center in Houston.
Bear Case
- Small market capitalization and limited financial resources.
- Negative profitability and high operating losses.
- Dependence on the evolving regulatory landscape of the medical cannabis industry.
- Limited brand recognition and market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CHNC Latest News
-
Stocks That Hit 52-Week Lows On Thursday
· Nov 21, 2019
-
Stocks That Hit 52-Week Lows On Friday
· Oct 11, 2019
-
Stocks That Hit 52-Week Lows On Wednesday
· Oct 2, 2019
Leadership: Dante Picazo
Managing
Dante Picazo is the managing individual at China Infrastructure Construction Corp. His role involves overseeing the company's operations, strategy, and growth initiatives. Given the company's small size of 2 employees, Mr. Picazo likely has a hands-on approach, managing various aspects of the business from educational program development to clinical service oversight. His leadership is crucial in navigating the evolving medical cannabis industry and driving the company's strategic direction.
Track Record: Due to limited information available, Dante Picazo's specific achievements and strategic decisions at China Infrastructure Construction Corp. Assessing his track record would require further insights into the company's performance and key milestones under his leadership. The company's current financial status, including its negative profitability, suggests potential challenges in his tenure.
CHNC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that China Infrastructure Construction Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, leading to increased risks for investors. Investing in OTC Other stocks requires thorough due diligence and an understanding of the potential risks involved compared to stocks listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited Disclosure: Lack of regular financial reporting increases information asymmetry and risk.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Susceptibility to significant price swings due to limited trading activity.
- Potential for Manipulation: Increased risk of market manipulation due to less regulatory oversight.
- Going Concern Risk: Higher risk of business failure compared to companies on major exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue streams and profitability.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Established Business: Founded in 2003, indicating some operational history.
- Specialized Services: Focus on medical cannabis education and related services.
- Physical Location: Operates a fertility and sleep center in Houston, Texas.
- Online Presence: Offers online education programs through Pharmacology University.
Common Questions About CHNC (Healthcare)
What happened to China Infrastructure Construction Corp. (CHNC) stock?
China Infrastructure Construction Corp. (CHNC) no longer trades on public markets. The figures below are historical and are not a current quote.
Can I still buy CHNC shares?
No. CHNC stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CHNC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CHNC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to China Infrastructure Construction Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does China Infrastructure Construction Corp. do?
China Infrastructure Construction Corp. operates primarily in the medical cannabis education and services sector. Through its Pharmacology University, the company provides online education programs focused on medical cannabis applications.
What are the key growth opportunities for CHNC in healthcare?
China Infrastructure Construction Corp. can capitalize on several growth opportunities within the healthcare sector. Expanding its online education programs to reach a broader audience, particularly in emerging markets with increasing acceptance of medical cannabis, presents a significant avenue for growth.
What are the main risks for CHNC?
China Infrastructure Construction Corp. faces several risks inherent to its business model and the evolving medical cannabis industry. Regulatory changes and legal restrictions on medical cannabis pose a significant threat, as changes in legislation can impact the company's operations and market access.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited due to the company's OTC listing and disclosure status.